Last update 20 Mar 2025

Recombinant basic fibroblast growth factor(Beijing SL Pharmaceutical Co., Ltd.)

Overview

Basic Info

Drug Type
Growth factors
Synonyms
Recombinant Human Basic Fibroblast Growth Factor Gel, Recombinant Human Basic Fibroblast Growth Factor for External Use, 重组人碱性成纤维细胞生长因子（双鹭药业）
+ [1]
Target
FGFRs
Action
stimulants, inducers
Mechanism
FGFRs stimulants(Fibroblast growth factor receptors stimulants), Angiogenesis inducers
Therapeutic Areas
Other Diseases
Active Indication
Burns
Inactive Indication-
Originator Organization
Beijing SL Pharmaceutical Co., Ltd.Beijing SL Pharmaceutical Co., Ltd.
Active Organization
Beijing SL Pharmaceutical Co., Ltd.Beijing SL Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (03 Feb 2000),
Burns
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Recombinant basic fibroblast growth factor(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant basic fibroblast growth factor(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant basic fibroblast growth factor(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data
100 Deals associated with Recombinant basic fibroblast growth factor(Beijing SL Pharmaceutical Co., Ltd.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
D03
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Burns
China
Beijing SL Pharmaceutical Co., Ltd.Beijing SL Pharmaceutical Co., Ltd.
03 Feb 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free